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Abstract
AIM
To systematically review the results of studies looking 
at autologous matrix-induced chondrogenesis (AMIC) in 
humans. 
METHODS
A literature search was performed, adhering to the 
PRISMA guidelines, to review any studies using such 
techniques in humans. Our initial search retrieved 297 
articles listed on MEDLINE, Google Scholar, CINHal and 
EMBASE. From these studies, 15 studies meeting the 
eligibility criteria were selected and formed the basis of 
our systematic review.
RESULTS
The study designs, surgical techniques and outcome 
measures varied between the studies. Although all 
studies reported improvements in patient outcome 
measures, this was not necessarily correlated with 
magnetic resonance imaging findings. Although there 
were many additional procedures performed, when 
AMIC was performed in isolation, the results tended to 
peak at 24 mo before declining. 
CONCLUSION 
Although short-term studies suggest improved patient 
reported outcomes with a variety of scaffolds, surgical 
techniques and rehabilitation regimes, the literature 
remains equivocal on whether the defect size and 
location, and patient factors affect the outcome. Patient 
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benefit appears to be maintained in the short-to-
medium term but more high level studies with extensive 
and robust validated outcome measures should be 
conducted to evaluate the medium- and long-term 
effect of the AMIC procedure.
Key words: Autologous matrix-induced chondrogenesis; 
Cartilage defects; Humans, PRISMA
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Studies looking at autologous matrix-induced 
chondrogenesis (AMIC) in humans suggest improved 
patient reported outcomes in the short-to-medium 
term but there is significant variation in the scaffolds, 
surgical techniques and rehabilitation regimes used. The 
literature remains equivocal on whether the defect size 
and location, and patient factors affect the outcome. 
More high level studies with extensive and robust 
validated outcome measures should be conducted to 
evaluate the medium- and long-term effect of the AMIC 
procedure.
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INTRODUCTION
Cartilage defects have a limited capacity for repair[1,2]. 
Untreated focal defects have the potential to progress 
to more generalised lesions and can cause significant 
morbidity. The frequent outcome for arthritis in large 
joints such as the knee is surgical intervention for joint 
replacement. This procedure is generally successful in 
older sedentary patients, but the limited lifetimes of 
prostheses make it much less desirable for younger 
and develop new strategies for the treatment of focal 
cartilage defects to prevent secondary osteoarthritis.
Various surgical procedures have been implemented 
to reduce pain, and postpone or prevent the need for 
joint replacement, while simultaneously withstanding 
the daily activities of the patient[3]. These include the 
use of bone marrow stimulation techniques pioneered 
by Pridie by introducing the concept of subchondral 
drillingPridie[4,5]. This was further developed by Stead­
man who introduced the notion of microfracture[6]. A 
range of chondrocyte implantation techniques have 
also developed including autologous chondrocyte 
implantation (ACI), matrix­induced autologous chondro­
cyte implantation (MACI), mosaicplasty and osteo­
chondral autologous transplantation (OATS)[7­10]. 
In 2003 after funding issues were raised for two­
step procedures such as ACI and MACI partly in view 
of associated costs, a new one­step procedure was 
introduced for the repair of cartilage defects called 
autologous matrix­induced chondrogenesis (AMIC) 
that brings together microfracture with a collagen 
matrix scaffold[11]. There is increasing interest in AMIC 
as it provides a cost­effective alternative to cell­based 
therapies for articular cartilage repair, and it is highly 
autologous in nature. Benthien and Behrens[1] first 
described the AMIC procedure using an awl to perform 
perforations in the subchondral bone, and “partial 
autologous fibrin glue” (PAF) using commercially avail­
able fibrin glue to adhere Chondro­Gide® (Geistlich 
Biomaterials, Wolhausen, Switzerland) collagen mem­
brane to the lesion. The TGFβ component of fibrin 
may contribute to the chondrogenic differentiation of 
mesenchymal stem cells (MSCs)[10]. Since then the 
procedure has been described with variations in the 
drilling technique, scaffold and fixation. 
The results with AMIC in the literature have been 
variable. As there are limited studies on AMIC, vari­
ability in the type of scaffold used[12­15], the surgical 
procedure[1,13,15­17], defect size and location, and 
patient variability may all contribute to variable results. 
In addition, we are not aware of the longevity of 
these results. We performed a systematic review of 
the literature identifying studies looking at AMIC to 
determine their clinical outcome, and address these 
three questions: (1) does the type of scaffold, surgical 
technique or rehabilitation regime affect outcome? (2) 
does the defect size and location, and patient factors 
affect outcome? and (3) does the outcome change with 
time?
MATERIALS AND METHODS
A systematic review of the published literature was 
conducted following Preferred Reporting Items for 
Systematic Reviews and Meta­Analysis Guidelines[18]. 
This search was completed on November 30, 2016 
using search databases MEDLINE, Google Scholar, 
Cumulative Index to Nursing and Allied Health Litera­
ture, AMED and EMBASE. No restrictions regarding 
publication date were applied during the literature 
search, due to the relatively new nature of AMIC 
and the limited number of related articles that have 
been published. Keywords used in the search include 
“autologous matrix­induced chondrogenesis” and 
“AMIC”. The Cochrane library was also searched using 
the terms “autologous matrix­induced chondrogenesis” 
and “AMIC”. Abstracts of the selected articles were 
reviewed to ensure they met the selection criteria, after 
which the full article was obtained. The bibliographies 
and in­text references of the retrieved articles were 
searched for any articles that may have been missed 
during the initial search. Unpublished or grey literature 
was identified using databases including System for 
Information on Grey Literature in Europe, the National 
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Technical Information Service, the National Research 
Register (United Kingdom), UKCRN Portfolio Database, 
the National Technical Information Service, the British 
Library’s Integrated Catalogue, and Current Controlled 
Trials database. Published and unpublished material 
including university theses and dissertations, and 
conference proceedings in the English literature were 
also reviewed. 
The inclusion criteria were clinical studies in English 
language looking at outcomes after AMIC in partial­ and 
full­thickness focal chondral or osteochondral defects 
(ICRS grade III or IV) of any joint. Studies with a level 
of evidence I­IV as described by the Oxford Centre for 
Evidence­based Medicine[19] were included. Studies 
not meeting these criteria, single­patient case studies, 
techniques, comments, letters, editorials, protocols and 
guidelines were excluded. Animal and cadaveric studies 
were also excluded.
The titles and abstracts of all citations were 
reviewed by the three authors (Shaikh N, Seah MKT 
and Khan WS). Full manuscripts of citations adhering 
to the inclusion criteria and those that were uncertain 
were downloaded. Reference lists of all full manuscripts 
and applicable review articles were reviewed to 
identify any further articles omitted from the initial 
search. The same investigators then reviewed all full 
manuscripts against the inclusion criteria and any 
disagreement on eligibility was resolved by discussion. 
The corresponding author of the paper was contacted 
if any queries arose. They were also consulted as to 
any additional citations that may address the research 
question.
Data was extracted from papers that satisfied the 
eligibility criteria. The variables that were determined 
for each study were study type, treatment period, 
study size, gender, mean age, patients lost to follow­
up, mean and range of follow­up, joint involved, size, 
grade and location of lesion, inclusion and exclusion 
criteria, source of funding, surgical technique, previous 
and associated surgeries, rehabilitation and outcome 
scores. The extracted data was entered onto Microsoft 
Excel (Microsoft Corporation, Washington, DC) by one 
investigator (Shaikh N), and re­evaluated and verified 
by the other authors (Seah MKT and Khan WS). The 
investigators were blinded to the source or authors of 
the identified papers. Although the systematic review 
protocol was approved by the host institution, the 
systematic review protocol was not formally registered 
in a registry. A systematic review was performed rather 
than a meta­analysis in view of the lack of randomised 
controlled trials and consistent outcome measures, 
where the results could be combined to allow statistical 
analyses. 
Study quality assessment
The Coleman Methodology Score (CMS)[20] was used 
to evaluate the quality of the studies and to determine 
if the outcomes and claims made in particular studies 
should be given more weighting than others. The 
ratings were also used as a guide to assess the level of 
confidence from which conclusions could be drawn from 
a particular study. CMS consists of two parts; Part A 
that focuses on the design of the study and Part B that 
relates to the study outcomes. This instrument uses a 
scaling system, in which the studies are assessed using 
10 criteria. Part A has a maximum total score of 65, 
while Part B has a maximum total score of 35, giving 
a total score of 100. The total score can be graded as 
being excellent (85­100 points), good (70­84 points), 
fair (55­69 points) and poor (< 55 points). A higher 
total score suggests that the study has an efficient 
design and is better at avoiding the effects of chance, 
various biases and confounding factors. The categories 
used in the CMS were formed on the basis of the 
Consolidated Standards of Reporting Trials statement 
for randomized controlled trials[21]. 
RESULTS
The results of the search using the databases retrieved 
297 articles. Twenty­six articles were reviewed after 
excluding animal and pre­clinical studies, single­
patient case reports, literature reviews and articles 
where the original text was in a language other than 
English. Of the 26 articles obtained, 10 were excluded 
as they represented level V evidence, review studies 
or technical notes, resulting in a total of 16 articles 
that were included in this systematic review (Figure 
1)[3,13,15­17,22­33]. Of the 16 included articles, 13 studies 
were prospectively conducted, 2 were retrospective, 
and only 1 was a randomized control trial.
There were more males than females included in 
the studies, with a ratio of approximately 2:1. The 
mean age was 36.2 years (range 15­50 years) and the 
mean follow­up period was 30 mo (range 6­62 mo). 
Ten of the 16 studies focussed on the knee, 3 on the 
ankle, and 3 on the hip (Table 1). Some of the studies 
mentioned sources of funding, but none that would 
trigger any concerns about conflict of interests or bias. 
A variety of treatment algorithms were used including 
different drilling techniques, scaffold used, method 
of fixation, associated surgery and the rehabilitation 
protocol (Table 2). 
All of the studies adopted at least one form of esta­
blished patient­reported outcome measure and 9 of 
the 16 studies obtained patient Magnetic resonance 
Observation of CArtilage Repair Tissue (MOCART) 
scores (Tables 3 and 4). For the 10 studies looking at 
the knee, all reported more than one clinical outcome 
measure. Five used the Visual Analogue Scale (VAS), 
4 used the Lysholm score and the Knee injury and 
Osteoarthritis Outcome Score (KOOS), 3 used the 
International Knee Documentation Committee (IKDC) 
score, 2 used the International Cartilage Repair 
Society (ICRS) and the Cincinnati score, and 1 used 
the Tegner score and Kujala patellofemoral score. 
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The three studies looking at the ankle joint used the 
American Orthopaedic Foot and Ankle Society (AOFAS) 
score and the VAS. One study also reported the Foot 
Function Index (FFI). Two of the hip studies reported 
the modified Harris Hip Score (mHHS). Four knee, four 
ankle and one hip studies also reported on MOCART 
scores. Although positive patient­reported outcomes 
were observed in all studies, MOCART scores did not 
always correlate with the patient­reported outcomes. 
Kusano et al[22] found significant improvements in 
the IKDC and Lysholm scores, but the MOCART scores 
did not correlate with the positive clinical outcomes. 
The majority of patients displayed incomplete defect 
repair, damaged repair tissue, and inhomogeneous 
repair tissue structure, as well as subchondral lamina 
and subchondral bone that were not intact. The 
randomized control trial by Anders et al[3] assessed dif­
ferences between a microfracture technique, a sutured 
AMIC technique, and a glued AMIC technique. In all 
three groups, positive patient outcomes and pain 
levels were observed at follow­up, with no significant 
differences between the groups. In assessing the 
magnetic resonance imaging (MRI) outcomes of pati­
ents in this study, results showed good defect filling 
in most patients, however homogenous repair tissue 
was only seen in 50% of the patients treated using the 
AMIC techniques, compared to 100% of the patients 
treated using traditional microfracture. Additionally, 
surface regeneration and integration of the lesion 
with the cartilage proved to be marginally inferior in 
patients that were treated using AMIC. The finding 
that MRI scores do not always correspond with patient­
assessed outcomes is consistent with those observed 
in other studies. Dhollander et al[29] found favourable 
clinical outcome scores in patients undergoing AMIC 
at the patellofemoral joint but the radiological findings 
did not support these outcomes. All 10 patients 
had subchondral lamina changes on MRI and 3 had 
osteophytes within 24 mo. 
Does the type of scaffold, surgical technique or 
rehabilitation regime affect outcome?
There are three commercially available biodegradable 
membrane scaffolds that fill in the lesions until they are 
absorbed and replaced by repair tissue (Table 2). The 
three scaffolds are Chondro­Gide®, Chondrotissue® 
(BioTissue, Zurich, Switzerland) and Hyalofast™ (Fidia 
Advanced Biopolymers, Padua, Italy). Chondro­Gide® is 
a porcine­based membrane that is the original and most 
popular scaffold used in AMIC. This protein­based matrix 
has a bi­layer structure composed primarily of type I/III 
collagen. In cases where the AMIC Plus technique[16] 
was implemented, a Platelet­rich plasma (PRP) gel 
(GPS® III System Advantages, Biomet) was applied 
to the surface of the lesion prior to the application 
of the membrane. Chondrotissue® is “sponge­like” 
matrix composed of polyglycolic acid treated with 
hyaluronan[12,13]. In cases where Chondrotissue® was 
used, PAF was substituted with biodegradable pins[13]. 
The HyalofastTM membrane is a partially­synthetic by­
product of hyaluronic acid composed of an unstructured 
amalgamation of fibres. On degradation it releases 
hyaluronic acid into the defect site that may encourage 
chondrogenic differentiation of bone marrow­derived 
MSCs[14]. Prior to commencing the AMIC procedure, 
bone marrow is aspirated from the iliac crest, and 
processed to obtain bone­marrow derived MSCs. This 
is used with autologous PRP obtained from the blood 
sample, and together the HyalofastTM membrane is 
immersed in this solution prior to being applied onto 
defect[15]. Buda et al[15] performed the AMIC procedure 
on 20 patients using HyalofastTM membrane, and the 
improvements in the IKDC scores were greater than 
those seen with Chondro­Gide® membrane. The mean 
Studies identified as potentially relevant 
and screened for retrieval = 298
Animal studies, in vitro research, single-patient 
case reports, literature reviews and original text in 
language other than English excluded = 272
Studies retrieved for further in depth 
evaluation = 26
Studies excluded as level V evidence, 
review studies, technical notes = 10
Relevant studies retrieved and included in this 
systematic review = 16
Figure 1  Illustration of the selection process for articles in this systematic review.
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  Ref. Treatment 
period
Patient 
numbers
Mean 
age 
(yr)
Mean 
follow-
up in 
months 
(range)
Joint Defect 
location and 
type
Grade of 
lesion
Lesion 
dimensions 
(cm2)
Inclusions Exclusions Source of 
funding
  Shetty et al[34] 4 yr 30 MFC, LFC, 
trochlea, 
patella
Grade 
III/IV
2-8 Malalignment 
of the knee 
exceeding 5° of 
valgus or varus. 
Generalized 
osteoarthritic 
changes in the 
knee
  Buda et al[15] Apr 
2006-May 
2007
20 (12M, 
8F)
15-50 29 Knees Grade 
III/IV
Not 
specified
Diffuse 
arthritis, 
general medical 
conditions 
(e.g., diabetes, 
rheumatoid 
arthritis etc.), 
haematological 
disorders and 
infections
None
  Gille et al[26] 2003-2005 27 (16M, 
11F)
39 37 
(24-62)
Knees Medial 
femoral 
condyle 7, 
lateral femoral 
condyle 3, 
patella 9, 
trochlea 
2, femoral 
condyle and 
patella 6
Grade IV > 1 Clinical 
symptomatic 
chondral 
lesions at 
femoral 
condyle, 
patella or 
trochlea
Advanced 
osteoarthritis, 
rheumatic 
disease, total 
menisectomy, 
BMI > 35, 
deviation of 
mechanical axis 
to the affected 
compartment
Not 
specified
  Dhollander et al[16] Jan 2008-Apr 
2008
5 (3M, 2F) 18-50 24 
(12-24)
Knees Patella Grade 
III/IV
2 (range 
1-3)
Symptomatic 
focal patella 
cartilage 
defects
Untreatable 
tibiofemoral or 
patellofemoral 
malalignment, 
diffuse 
osteoarthritis, 
major meniscal 
deficiency or 
other general 
medical 
conditions
Not 
specified
  Dhollander et al[13] 2008-2009 5 (4M, 1F) 29.8 24 Knees Right 2 (40%), 
left 3 (60%)
medial 
femoral 
condyle (2), 
lateral femoral 
condyle (2), 
trochlea (1)
Grade 
III/IV
Median 
2.3, range 
1.5-5
16-40 yr, single 
symptomatic 
focal cartilage 
defect on 
femoral 
condyles or 
patellofemoral 
joint 
Untreated 
tibiofemoral or 
patellofemoral 
malalsignment 
or instability, 
diffuse 
osteoarthritis, 
bipolar 
“kissing” 
lesions, major 
meniscal 
deficiency 
and other 
general medical 
conditions
Not 
specified
  Kusano et al[22] Aug 2003-Jul 
2006
40 (23M, 
17F)
35.6 28.8 
(13-51)
Knees Full thickness 
chondral 
defect in 
patella (20), 
femoral 
condyle (9),  
osteochondral 
defect in 
femoral 
condyle (11)
Grade 
III/IV
3.87 Defects in other 
locations, age > 
50 yr, skeletally 
immature
Not 
specified
Table 1  Study demographics, lesion location and grade, inclusion and exclusion criteria, and funding sources
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  Leunig et al[23] Mar 2009-Dec 
2010
6 (5M, 1F) 22.7 Not 
specified 
(12-30)
Hips Femoral head 
5, acetabular 1
chondral 1, 
osteochondral 
5
Grade 
III/IV
> 2 Full thickness 
chondral 
lesions > 
2 cm2 or 
osteochondral 
lesions > 1 cm2 
with defects in 
weight-bearing 
areas of 
acetabulum or 
femoral head, 
irreparable by 
osteotomy in 
age < 35 yr
Patients 
unwilling 
or unable to 
comply with 
post-operative 
rehabilitation 
protocols. 
Systematic 
inflammatory 
arthritis, 
advanced 
arthritis 
involving both 
femur and 
acetabulum, or 
age > 35 yr
Not 
specified
  Pascarella et al[24] 2006-2008 19 (12M, 
7F)
12-36 Knees Right knee: 
Femoral 
condyle 
(medial 34%, 
lateral 14%), 
patella (9%)
Left knee:
Femoral 
condyle 
(medial 29%, 
lateral 14%)
Grade 
III/IV
3.6 Age 18-50 yr 
with single 
lesion
Osteoarthritis, 
axial 
deviations, 
ligamentous 
injuries, 
complete 
meniscal 
resection, 
allergy to 
collagen 
membrane 
components
Not 
specified
  Anders et al[3] Jan 2004-Mar 
2010
38 (Not 
specified)
37 19 (6-24) Knees Grade 
III/IV
3.4 Age 18-50 yr, 
1-2 lesions 
> 2 defects, 
corresponding 
defects, 
bilateral 
defects, signs of 
osetoarthritis, 
other general 
diseases, 
history of 
complete 
menisectomy, 
mosaicplasty, 
treatment 
with cartilage 
specific 
medication, 
chondropathia 
patallae 
or patellar 
dysplasia 
None
  Gille et al[28] Not specified 57 (38M, 
19F)
37.3 24 Knees Medial 
condyle 
(32), lateral 
condyle (6), 
trochlea (4), 
patella (15) 
Grouping 
based on 
lesion size: 
Group A 0-3 
cm2, Group 
B 3-6 cm2, 
Group C 6-9 
cm2
Grade 
III (35), 
Grade IV 
(37)
3.4 (1-12) Age 17-61 yr Rheumatic 
disease, total 
meniscectomy, 
and revision 
surgery
Not 
specified
  Valderrabano et al[17] 26 (18M, 
8F)
33 31 
(25-54)
Ankles
 
Osteo-
chondral 
lesions of 
talus 
1.68 First time 
osteochondral 
lesion or failure 
of previous 
lesion
Age > 55 yr, 
open ankle 
physis 
Not 
specified
  Wiewiorski et al[25] 2008-2010 23 (16M, 
7F)
34 23 
(11-49)
Ankles 
(talus)
Osteo-
chondral 
lesions of 
talus
Osteo-
chondral
1.49 Single lesion 
with history of 
ankle trauma
Not 
specified
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KOOS score at follow­up in this study were significantly 
greater than those reported by Dhollander et al[16,29] 
using Chondro­Gide® and in Dhollander et al[13] using 
Chondrotissue. The clinical outcomes achieved in Buda 
et al[15]’s study were partly supported by the MOCART 
scores, with a majority of patients displaying complete 
defect repair, complete integration to surrounding carti­
lage, intact repair tissue surface, and isointense signal 
intensity, while other MRI measures showed poor 
results despite positive patient­assessed outcomes. The 
remainder of the studies in this review used Chondro­
Gide® and resulted in patient outcomes that were posi­
tive and comparable. 
Several drilling techniques were adopted in the 
studies. In 6 of the 16 studies, an awl was used to 
perforate the subchondral surface of the bone as 
originally described[1]. Seven studies substituted an awl 
with a microdrill, with or without Kirchner wires[23,24]. 
Pascarella[24] carried out a slightly modified AMIC 
procedure with the intention of increasing the number 
of MSCs to produce healthy regenerative cartilage. 
Perforations were performed rather than microfractures, 
and the covering of the focus of the lesion with a 
biological collagen patch enriched with bone marrow 
  Dhollander et al[29] April 
2009-May 
2011
10 (8M, 2F) 37.2 ± 
7.1
24 Knee Patella (8), 
trochlea (2)
Grade 
III/IV
4.2 ± 1.9 Patients aged 
18-50 yr 
with a focal 
patellofemoral 
defect and 
clinical 
symptoms 
(pain, swelling, 
locking, giving 
way) 
Untreatable 
tibio-femoral or 
patellofemoral 
mal -
alignment or 
instability, 
diffuse 
osteoarthritis 
or bipolar 
“kissing” 
lesions, major 
meniscal 
deficiency 
and other 
general medical 
conditions 
(diabetes, 
rheumatoid 
arthritis)
Not 
specified
  Mancini et al[30] November 
2004-June 
2007
31 36.4 ± 
10.3
60 Hip Acetabular 
chondral 
defects
Grade 
III/IV
2-4 Patients 18-50 
yr of age with 
acetabular 
chondral 
lesions with 
radiological 
Tönnis degree 
< 2
followed up to 
5 yr
Concomitant 
chondral 
femoral head 
kissing lesion, 
systemic 
rheumatoid 
diseases, 
dysplasia,
femoral 
neck axial 
deviations, 
coxa profunda, 
protrusio
acetabuli
Not 
specified
  Fontana et al[31] November 
2004-March 
2011
55 39.1 
(18 to 
55)
36-60 Hip Acetabular ± 
femoral head 
chondral 
defects
Grade 
III/IV
2-8 Patients 18-55 
years of age 
with acetabular 
± femoral head
chondral 
lesions 
with 
radiological 
Tönnis degree 
< 2
followed up for 
3-5 yr
Rheumatoid 
arthritis, 
dysplasia, axial 
deviation of the 
femoral neck, 
coxa profunda, 
protrusio 
acetabuli
Not 
specified 
but 
Girolamo 
is a paid 
consultant 
for 
Geistlich
  Kubosch et al[32] Not specified 17 38.8 ± 
15.7
39.5 ± 
18.4
Ankle Osteo-
chondral 
lesions of 
talus
Grade 
III/IV
2.4 ± 1.6 First-time
diagnosis 
or failure of 
a previous 
operative 
treatment
Arthritis of 
the ankle 
joint, kissing 
lesions and 
rheumatoid
arthritis
Not 
specified
BMI: Body mass index.
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  Ref. Drilling technique Scaffold/fixation Associated surgery Joint Rehab
  Buda et al[15] No drilling Hyalofast + PRP 3 osteotomy Knees NWB 4 wk, run 6 mo, RTS 
12 mo
  Gille et al[26] Awl/sharp cannula ChondroGide
Fibrin glue
2 realignments, 1 capsular 
shift
Knees Immobilization 1 wk, 
passive motion 6 wk, NWB 
6 wk
  Dhollander et al[16] Microdrill ChondroGide + PRP
Sutures
3 osteotomy + 1 medial 
patello-femoral ligament 
reconstruction
Knees NWB 2 wk, brace 0-90 for 4 
wk, full ROM at 8 wk, Low 
impact sports 12 mo
  Dhollander et al[13] Microdrill Chondrotissue
Pin
1 osteotomy Knees NWB 2 wk, 0-90o 4 wk, full 
range 8 wk, RTS 12 mo
  Kusano et al[22] Awl ChondroGide 
Suture/fibrin glue
28 osteotomy Knees PWB 6 wk, 0-60 4wk
  Leunig et al[23] Kirchner wire ChondroGide, fibrin glue 3 osteoplasty, 2 femoral 
neck lengthening, drilling 
of acetabular defects
Hips PWB 6-8 wk, passive motion 
6-8 h for 6-8 wk
  Pascarella et al[24] Kirchner wire ChondroGide
Fibrin glue
Knees
  Anders et al[3] Awl ChondroGide
Suture/fibrin glue
Knees PWB and lymphatic 
draining massage 3-6 wk, 
FWB at 4-6 mo, RTS 3-18 mo
  Gille et al[28] Awl ChondroGide
Fibrin glue
2 patella realignments, 3 
corrective osteotomies, 6 
partial menisectomies, 1 
ACL reconstruction
Knees
  Valderrabano et al[17] Microdrill ChondroGide
Fibrin glue
16 osteotomy Ankles PWB, ROM of < 200 passive 
motion machine, lymphatic 
drainage massage 6wks, 
FWB 6-12 wk, Light sports 
12 wk, RTS 5-6 mo
  Wiewiorski et al[25] Microdrill ChondroGide
Fibrin glue
Ankles (talus) PWB and lymphatic 
draining massage 6 wk, 
FWB 12 wk
  Dhollander et al[29] Slow speed
1.2 mm diameter 
ChondroGide
Vicryl 6/0
No Knees 
(Patellofemoral 
joint)
NWB for 2 wk, FWB at 10 
wk, full range of motion at 8 
wk, low impact sports 12 mo
  Mancini et al[30] Awl/sharp cannula ChondroGide
Fibrin glue
All patients had cam-
type and/or pincer-
type impingement, and 
underwent arthroscopic 
femoral head-neck 
resection arthroplasty 
and/or arthroscopic 
acetabular rim trimming 
and labral reattachment 
to the acetabular rim with 
suture anchors
Hips PWB (30% of body weight) 
for 4 wk, impact sports 3 
mo, complete RTS 6 mo
  Fontana et al[31] Awl/sharp cannula ChondroGide
Fibrin glue
All patients had cam-
type and/or pincer-
type impingement, and 
underwent arthroscopic 
femoral head-neck 
resection arthroplasty 
and/or arthroscopic 
acetabular rim trimming 
and labral reattachment 
to the acetabular rim with 
suture anchors
Hips PWB for 7 wk, light sporting 
activities 4 wk, low impact 
sports 6 mo, complete RTS 
12 mo
  Kubosch et al[32] Not specified ChondroGide
Fibrin glue
All patients also underwent 
autologous cancellous bone 
grafting to the site
Ankles (talus) Ankle immobilisation for 2 
wk, PWB for 6 wk
  Shetty et al[34] Microdrill Tiseel 
Coltrix (atelocollagen) 
- Knees PWB for 6 wk, gradual 
increase to FWB by next 6 
wk 
Table 2  Treatment algorithms
PRP: Platelet-rich plasma; ACL: Anterior cruciate ligament; PWB: Partial weight bearing; NWB: Non-weight bearing; FWB: Full weight bearing; ROM: 
Range of motion; RTS: Return to sport.
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studies[17,25] did not specify the grade of lesions. The 
studies focussed on both osteochondral and chondral 
defects of the joints. Although the lesions varied from 
1­8 cm2, the mean lesion size for all studies ranged 
from 1.5­3.6 cm2. In the ankle based studies all 
AMIC procedures were conducted on the talus, and a 
majority of the knee based studies involved the AMIC 
procedure being carried out on the femoral condyle. 
Kusano et al[22] compared 40 defects; 11 were 
Osteochondral Femoral Condyle lesions (ocF), 20 were 
Chondral Patella lesions (cP), and nine were Chondral 
Femoral Condyle lesions (cF). The ocF group had the 
lowest mean age at 25.9, while the mean age for the 
other groups was just below 40. Only 36% of patients 
in the ocF group had an osteotomy compared with 
90% in the cP group and 67% in the cF group. The 
cF group had a significantly smaller mean lesion size 
(2.3 cm2), compared with 4.2 and 4.4 cm2 in the other 
groups. The patient outcome scores were consistent 
across the groups. Although the cP group reported 
the highest mean pre­operative scores, the ocF group 
showed the greatest improvement at follow­up, and 
the cF group showed the least improvement. As 
there were inconsistencies between the three groups 
relating to age and size of lesion, it is difficult to draw 
a definitive conclusion from these results. Gille et al[26] 
followed up patients for 48 mo and failed to identify 
any significant effect of lesion size on Patient outcome 
scores. They did however find that outcomes were 
better for femoral condyle defects than patella defects, 
and the two patients who had cartilage defects greater 
than 8 cm2 did not benefit from the procedure. Fontana 
et al[31] compared AMIC with microfracture at the hip 
joint in patients undergoing impingement surgery, and 
only found a better five­year clinical outcome for the 
AMIC group for lesions greater than 4 cm2. 
Interestingly Fontana et al[31] only found the five­
year results to be better for the AMIC group in males, 
and not females. Looking at the remaining studies, 
males generally reported higher outcome scores but 
showed similar levels of improvement to females after 
treatment. In the study carried out by Kusano et al[22], 
the results suggested that younger patients generally 
experience greater improvements than older patients. 
Gille et al[26] reported on patient outcome scores at 48 
months, and failed to identify any significant effect of 
age, weight, gender, and previous surgery on patient 
outcome, but younger patients did generally display 
better recovery rates than older patients. 
Does the outcome change with time?
Mancini et al[30] and Fontana et al[31] reported five­year 
follow­up in patients undergoing AMIC at the hip joint 
but all patients underwent additional impingement 
surgery. The authors report improved outcome scores 
that were achieved at six months and generally 
maintained till final follow­up at five­years. Gille et al[26] 
reported on ICRS, Cincinnati, and Lysholm patient­
assessed scores at 24, 36, and 48 mo for patients 
undergoing AMIC at the knee joint with less than 10% 
of patients undergoing additional procedures. Patient 
recovery tended to peak at 24 mo before declining. 
The mean Cincinnati score peaked at 74 at 24 mo, 
and steadily declined to 62 (36 mo) and 37 (48 
mo). For all scoring systems, the patient outcomes 
deteriorated more rapidly once they passed the 36 
mo follow­up. The randomized control trial by Anders 
et al[3] compared a microfracture technique, a sutured 
AMIC technique, and a glued AMIC technique. None 
of the patients underwent any additional procedures. 
In all three groups, improvements in pain scores and 
patient outcomes, including Cincinnati scores, were 
observed at both 12 and 24 mo follow­up. Between 
12 and 24 mo follow­up, 12 patients showed further 
  Ref. Coleman methodology score
Part A, maximum = 65 Part B, maximum = 35 Total, max 
= 100
1 2 3 4 5 6 1 2 3
  Buda et al[15] 0 4   0 10 10 5 2 2 3 3 5 4 3 3 5 5 64
  Gille et al[26] 4 4   7 10 10 5 2 2 3 3 5 4 3 3 5 5 75
  Dhollander et al[16] 0 4 10 10 10 5 2 2 3 3 5 0 3 0 5 5 67
  Dhollander et al[13] 0 4 10 10 10 5 2 2 3 3 5 4 3 3 5 5 74
  Kusano et al[22] 4 4 10   0 10 5 2 2 3 3 5 0 3 3 5 5 64
  Leunig et al[23] 0 4 10   0 10 5 2 2 3 3 5 4 3 0 5 0 56
  Pascarella et al[24] 0 4 10 10   0 5 0 2 3 0 5 0 3 0 5 5 52
  Anders et al[3] 4 0   0 10 10 5 2 2 3 3 5 0 3 0 5 0 52
  Gille et al[28] 7 4 10   0   0 0 2 2 3 3 5 0 3 0 5 5 49
  Valderrabano et al[17] 0 4 10 10 10 5 2 2 3 3 5 0 3 0 5 5 67
  Wiewiorski et al[25] 0 4 10 10 10 0 2 2 3 0 0 0 3 3 5 5 57
  Dhollander et al[29] 0 4 10   0 10 5 2 2 3 3 5 0 3 3 5 5 60
  Mancini et al[30] 4 7   0 10   5 5 2 2 3 0 5 0 3 3 5 5 59
  Fontana et al[31] 7 7   0 10   5 5 2 2 3 0 5 0 3 3 5 5 62
  Kubosch et al[32] 0 7 10   0   0 5 2 2 3 3 5 0 3 3 5 5 53
  Shetty et al[34] 4 7 10   0   0 5 2 2 3 3 5 0 3 3 5 0 52
Table 5  Coleman methodology scores for the 15 reviewed studies reporting on autologous matrix-induced chondrogenesis
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improvement in Cincinnati scores, 12 showed little or 
no change, and 3 showed a decline. 
Methodological quality assessment
CMS was used to assess the methodological quality 
of the studies carried out using the AMIC procedure 
(Tables 5 and 6). The mean CMS and standard 
deviation (SD) achieved was 60.7 ± 7.9 (range 49­75) 
out of 100. The mean CMS and standard deviation (SD) 
achieved in Part A was 31.8 ± 5.9, and in Part B was 
28.9 ± 4.1. 
DISCUSSION
AMIC enables the transplantation of a scaffold with 
MSCs in one step, avoiding the need for laboratory 
cell number expansion and a second procedure[26]. In 
our review, 15 studies between 2003 and 2015 that 
used AMIC for the repair of articular cartilage defects 
in patients were systematically reviewed. AMIC is still 
a relatively new procedure and more mid­term and 
long­term outcomes are awaited. The mean CMS 
suggesting that the overall quality of the studies was 
fair. Studies scored poorly for number of patients, 
length of follow­up, study design and independence 
of the investigator and the surgeon. For Part A, the 
overall mean CMS was 31.8 out of 65 points (49%), 
whereas for Part B the overall mean CMS was 28.9 out 
of 35 (72%). This indicates that overall, the studies 
were more competent in defining their outcome criteria 
and procedures, and that greater improvements 
need to be made regarding study design and pro­
cedures. Although blinding of participants has ethical 
implications, blinding of clinicians recording the out­
come measures was not practised commonly. In 
scoring systems that require completion by an investi­
gator, it is recommended that the investigation be 
carried out by an independent investigator to ensure 
accurate responses from the patient avoiding risk of 
bias through patient­investigator relationships. Several 
authors contributed to multiple studies included in this 
review introducing a risk of bias in both study design 
and reporting of outcomes across the studies. 
The studies included in this review were not directly 
comparable due to differences in study design, lesions, 
surgical technique, follow­up and outcome measures. 
Although the AOFAS score was used in all three ankle 
studies and the mHHS in two of the three hip studies, 
there were no consistent scoring systems used for 
the knee studies. Nevertheless, a pattern of positive 
patient outcomes can be seen across all of the studies. 
Future studies should incorporate a universal method of 
rating patient outcomes for each joint location, allowing 
direct comparison of results. There also is a need to 
determine whether MRI assessment is a reliable tool 
as the studies in our review suggest that it does not 
necessarily correspond with patient outcome measures. 
Nevertheless, we recommend that all studies should 
continue to carry out an MRI assessment while further 
evidence on its relevance is sought. 
Many of the studies included patients that required 
additional surgical procedures including osteotomies. 
For a patient undergoing more than one surgical 
procedure it would be difficult to determine the effect 
of each procedure in relieving pain and improving joint 
function. There is a distinct lack of consensus regarding 
post­operative management and the structure of 
rehabilitation programmes. Rehabilitation programs 
can have a significant influence on patient outcomes 
and recovery rates. Although it is difficult to develop 
a universal rehabilitation program due to the large 
number of variables such as patient demographics, and 
  Section score (maximum) Mean Range SD
  Part A (65)
     Study size     2.1 0-7    2.6
     Minimum follow-up    4.5 0-7    1.7
     Number of different surgical treatment included    7.3 0-10    4.3
     Study design    6.3 0-10    4.8
     Description of surgical technique    6.9 0-10    4.3
     Post-Op management described    4.4 0-5    1.7
  Total part A   31.4 21-40    5.7
  Part B (35)
     Outcome measures clearly defined    1.9 0-2    0.5
     Timing of outcome clearly stated 2 2 0
     Use of reliable outcome criteria 3 3 0
     General health measure inc.    2.2 0-3    1.3
     Subjects recruited    4.7 0-5    1.2
     Inv. independent of surgeon 1 0-4    1.7
     Written assessment 3 3 0
     Completion of assessment by patients with minimal investigator assistance    1.9 0-3    1.5
     Selection criteria reported and unbiased 5 5 0
     Recruitment rate reported    4.1 0-5 2
  Total part B  28.9 23-35    3.9
  Total, maximum = 100 60.2 49-75    7.7
Table 6  Coleman methodology scores - mean, range and standard deviation for each section 
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lesion size and location, this needs to be considered 
when comparing outcomes between different studies. 
Due to the variation in studies it is not possible to 
determine if the type of scaffold, surgical technique or 
rehabilitation regime affect the outcome.
Limited studies suggest that femoral condyle 
lesions do better than patellar lesions, and osteo­
chondral defects do better than chondral lesions. 
Defect sizes did not generally have an effect on the 
patient’s outcome unless the defect was > 8 cm2, in 
which case it had a detrimental effect on outcomes. 
There is limited evidence that younger patients 
experience greater improvements than older patients 
and display better recovery rates. It has been shown in 
vitro that bone marrow stem cells from older patients 
have reduced chondrogenic potential compared 
with younger patients, potentially decreasing the 
effectiveness of AMIC in older patient groups. 
Follow­up period is an important factor in assessing 
the real effectiveness and reliability of the AMIC 
procedure. Since the treatment method is relatively 
new, there is a lack of long­term patient outcome 
data available. A longer follow­up period allows the 
proper assessment of long term outcomes for a 
procedure. Although five­year follow­up was available 
for two studies[30,31], the patients had all undergone 
additional procedures making any improvements 
difficult to attribute to the AMIC procedure alone. It 
was demonstrated in the study conducted by Gille et 
al[26] and Gudas, Gudas et al[27] that declines in clinical 
outcomes can be observed as early as 18 to 24 mo 
after undergoing surgical treatment without additional 
procedures. Patient assessed outcomes by Gille et 
al[26] declined significantly between the 24 mo and 
48 mo post­operative period, indicating that there 
may be concerns regarding durability of the repaired 
cartilage after undergoing the AMIC procedure. In 
the randomized control trial by Anders et al[3] improve­
ments in pain scores and patient outcomes, including 
Cincinnati scores, were observed at 12 mo follow­up. 
Between 12 and 24 mo follow­up, although 12 patients 
showed further improvement in Cincinnati scores, 12 
showed little or no change, and 3 showed a decline. 
This supports the observation by other studies, and 
their 5­year follow­up results are awaited. 
The published literature reviewed suggests that 
AMIC in cartilage repair is a safe and effective treat­
ment option that improves patient outcome measures 
and reduces pain. MRI findings however do not 
necessarily correspond with patient outcome measures. 
Most studies reported promising results, with no 
mention of further surgical corrections being needed in 
the follow­up period. Medium­ and long­term results 
for AMIC procedures without additional surgeries are 
awaited. Earlier studies suggest that AMIC results may 
peak at around 24 mo. 
The CMS results suggest that the clinical trials 
evaluated in this systematic review were of fair to 
reasonable quality; with 8 of the 15 studies achieving 
total CMS scores ranging from 60 to 80. The main 
weaknesses across the studies were the total number 
of participants and the patient follow­up periods. 
Improvements in these areas will significantly increase 
the reliability of the patient outcome measures, 
while allowing investigators to draw more definitive 
conclusions. More high level studies with larger sample 
sizes, and extensive and robust validated outcome 
measures should be conducted to evaluate the me­
dium­ and long­term effect of the AMIC procedure.
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The results with autologous matrix-induced chondrogenesis (AMIC) in the 
literature have been variable. As there are limited studies on AMIC, variability in 
the type of scaffold used, the surgical procedure, defect size and location, and 
patient variability may all contribute to variable results. In addition, we are not 
aware of the longevity of these results. 
Research frontiers
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